PRECIS Adjusting for sociodemographics and comorbidities, patients with glaucoma incur an annual incremental economic burden of 1863.17, translating to .2 billion nationally. When analyzed by the health care service sector, prescription medication expenditures were higher for glaucoma patients. PURPOSE The purpose of this study was to estimate the incremental health care burden, defined as attributable costs solely due to a diagnosis, of patients with diagnosed glaucoma, controlling for comor...
An 82-year-old man with severe primary open angle glaucoma on maximal medical therapy underwent an ab externo closed conjunctival Xen45 device insertion with mitomycin C. The surgery was uncomplicated, with a first postoperative day intraocular pressure (IOP) of 4▒mmHg and visual acuity of 20/40 OD. Ten days later, the patient presented with an IOP of 5mmHg and a visual acuity of counting fingers at 5 feet. Examination showed Seidel negative bleb, shallow anterior chamber, and large non-appositi...
Precis null The inferior>superior>temporal rim width rate (IST pattern) rather than inferior≥superior≥nasal≥temporal (ISNT) pattern was suited for screening glaucoma in Japanese. Failure of the IST pattern was associated with several important risk factors for glaucoma. null Purpose null The purpose of this study was to find a rim width rate pattern to yield the highest positive likelihood ratio (LR+) in detecting glaucoma eyes and to identify risk factors for glaucoma correlating with its failu...
Precis null Patient education and dosing self-efficacy are important factors related to ongoing adherence to glaucoma topical treatment, and patients view their disease management as a shared effort with their provider. null Purpose null Glaucoma affects nearly 3 million Americans and medication adherence has been reported to be as low as 20% in this patient population; however, key limitations to our understanding of this behavior in adults with glaucoma exist. null Patient and methods null Thi...
PRECIS Intermediate term results suggest that ab-interno Minimally Invasive Micro Sclerostomy (MIMS) stent less subconjunctival filtration procedure is a promising treatment option for patients with open angle glaucoma. PURPOSE Minimally Invasive Micro Sclerostomy (MIMS) is a novel ab-interno, stent-less, subconjunctival filtration procedure. This study set to investigate the safety, performance and efficacy of MIMS in open angle glaucoma patients. METHODS Prospective, open-label, single arm cli...
Purpose null The purpose of this study was to report a case of infective necrotizing scleritis following XEN Gel Stent with mitomycin-C. null Methods null Case report. This is a case report of a 68-year-old woman. null Results null XEN Gel Stent glaucoma surgery enhanced with mitomycin-C 0.04% and combined with cataract surgery was performed at a regional center to manage the patient's primary open-angle glaucoma. Past medical history was significant for rheumatoid arthritis requiring treatment ...
Purpose null The purpose of this study was to describe anterior subcapsular cataract development in patients on long-term topical netarsudil use. null Patients and methods null This clinical observational study summarizes a similar cataract pattern demonstrated in a series of patients from a single physician practice and a university-based outpatient clinic during their routine clinical follow-up visits from October 2020 to August 2021. All patients have been using topical netarsudil once daily ...
PRCIS Multiple systemic vascular-associated conditions including systemic hypertension and hypotension, diabetes mellitus, migraine headache, peripheral vascular disease, Raynaud's Syndrome, anemia were associated with low tension glaucoma. PURPOSE To identify systemic risk factors associated with low tension glaucoma. MATERIALS METHODS A retrospective case-control study design was employed to identify patients seen at the Mayo Clinic Department of Ophthalmology between 2005 and 2015 with low te...
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies. To learn more, you can find in our Privacy Policy.